
Alaunos Therapeutics, Inc.
USD2.44
+0.07 (+2.95%)
CEO
Holger Weis
IPO Date
2005-08-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.44
Prev. Close
$2.37
Day Low
$2.44
Day High
$2.44
52W Low
$1.67
52W High
$6.20
Market Cap
$0.01B
Volume
0.00M
| 3 May 2022 |
| Wells Fargo |
| Equal Weight |
| Overweight |
| upgrade |
| 8 Nov 2021 | Raymond James | Market Perform | Market Perform | maintain |
| 9 Aug 2021 | Raymond James | Outperform | Market Perform | downgrade |
| 6 May 2021 | Raymond James | Outperform | Outperform | maintain |
| 11 Mar 2021 | Jefferies | Buy | Hold | downgrade |
| 28 Feb 2021 | HC Wainwright & Co. | Buy | Neutral | downgrade |
| 2 Mar 2020 | Raymond James | Outperform | Outperform | maintain |